Home » Consortium

Consortium

The imSAVAR consortium was formed to provide a diversity of expertise on the ambition to deliver a sustainable platform of nonclinical tests that can more accurately reflect disease states.

28 partners from 11 countries provide expertise in the fields of: Immuno-safety, microphysiological systems, cellular in vitro assays as well as animal models, in vivo models, specific modes of action and adverse events, development of novel biomarkers, Management of samples and of a network of sampling providing centres, Data and knowledge management, bioinformatics solutions data privacy, innovation management, patient stakeholder involvement, sustainability planning and project management.

# Academic

Universities, University Hospitals, a Federal Institute and Research Organisations from all over Europe are working together in imSAVAR.​

# EFPIA Companies​​

11 companies of the European Federation of Pharmaceutical Industries and Associations (EFPIA) participate in imSAVAR, representing the pharmaceutical industry operating in Europe.

# Associated Partners​

We have one non-profit research organisation joining as an IMI associated partner.

# SMEs

Within imSAVAR, we have 4 small-medium sized enterprises from Germany, Belgium and Luxembourg supporting the project.